Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Total article views   HTML views PDF downloads Totals
6,439 Dovepress* 5,114+ 109 5,223
PubMed Central* 1,325 248 1,573
Totals 6,439 357 6,796
*Since 3 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar